Engineering and manufacturing of pharmaceutical co-crystals

a review on solvent-free manufacturing technologies

S. A. Ross, D. A. Lamprou, D. Douroumis

Research output: Contribution to journalArticle

59 Citations (Scopus)
53 Downloads (Pure)

Abstract

Design and synthesis of pharmaceutical cocrystals have received great interest in the recent years. Cocrystallization of drug substances offer a tremendous opportunity for the development of new drug products with superior physical and pharmacological properties such as solubility, stability, hydroscopicity, dissolution rates and bioavailability. It is now possible to engineer and develop cocrystals via ‘green chemistry' and environmental friendly approaches such as solid-state synthesis in the absence of organic solvents. In addition, significant efforts are placed on computational screening, cocrystal manufacturing in a continuous manner and real-time monitoring for quality purposes by using various analytical tools. Pharmaceutical cocrystals are not fully exploited yet and there is a lot of ground to cover before they can be successfully utilized as medical products.
Original languageEnglish
Number of pages14
JournalChemical Communications
Early online date27 May 2016
DOIs
Publication statusE-pub ahead of print - 27 May 2016

Fingerprint

Drug products
Crystals
Pharmaceutical Preparations
Organic solvents
Screening
Dissolution
Solubility
Engineers
Monitoring
Biological Availability

Keywords

  • pharmaceutical cocrystals
  • drug development
  • drug substances
  • environmentally conscious manufacture

Cite this

@article{7dcf64fd9c6b4a81a3d44b14a1f532cb,
title = "Engineering and manufacturing of pharmaceutical co-crystals: a review on solvent-free manufacturing technologies",
abstract = "Design and synthesis of pharmaceutical cocrystals have received great interest in the recent years. Cocrystallization of drug substances offer a tremendous opportunity for the development of new drug products with superior physical and pharmacological properties such as solubility, stability, hydroscopicity, dissolution rates and bioavailability. It is now possible to engineer and develop cocrystals via ‘green chemistry' and environmental friendly approaches such as solid-state synthesis in the absence of organic solvents. In addition, significant efforts are placed on computational screening, cocrystal manufacturing in a continuous manner and real-time monitoring for quality purposes by using various analytical tools. Pharmaceutical cocrystals are not fully exploited yet and there is a lot of ground to cover before they can be successfully utilized as medical products.",
keywords = "pharmaceutical cocrystals, drug development, drug substances, environmentally conscious manufacture",
author = "Ross, {S. A.} and Lamprou, {D. A.} and D. Douroumis",
year = "2016",
month = "5",
day = "27",
doi = "10.1039/C6CC01289B",
language = "English",
journal = "Chemical Communications",
issn = "1359-7345",

}

Engineering and manufacturing of pharmaceutical co-crystals : a review on solvent-free manufacturing technologies. / Ross, S. A.; Lamprou, D. A.; Douroumis, D.

In: Chemical Communications, 27.05.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Engineering and manufacturing of pharmaceutical co-crystals

T2 - a review on solvent-free manufacturing technologies

AU - Ross, S. A.

AU - Lamprou, D. A.

AU - Douroumis, D.

PY - 2016/5/27

Y1 - 2016/5/27

N2 - Design and synthesis of pharmaceutical cocrystals have received great interest in the recent years. Cocrystallization of drug substances offer a tremendous opportunity for the development of new drug products with superior physical and pharmacological properties such as solubility, stability, hydroscopicity, dissolution rates and bioavailability. It is now possible to engineer and develop cocrystals via ‘green chemistry' and environmental friendly approaches such as solid-state synthesis in the absence of organic solvents. In addition, significant efforts are placed on computational screening, cocrystal manufacturing in a continuous manner and real-time monitoring for quality purposes by using various analytical tools. Pharmaceutical cocrystals are not fully exploited yet and there is a lot of ground to cover before they can be successfully utilized as medical products.

AB - Design and synthesis of pharmaceutical cocrystals have received great interest in the recent years. Cocrystallization of drug substances offer a tremendous opportunity for the development of new drug products with superior physical and pharmacological properties such as solubility, stability, hydroscopicity, dissolution rates and bioavailability. It is now possible to engineer and develop cocrystals via ‘green chemistry' and environmental friendly approaches such as solid-state synthesis in the absence of organic solvents. In addition, significant efforts are placed on computational screening, cocrystal manufacturing in a continuous manner and real-time monitoring for quality purposes by using various analytical tools. Pharmaceutical cocrystals are not fully exploited yet and there is a lot of ground to cover before they can be successfully utilized as medical products.

KW - pharmaceutical cocrystals

KW - drug development

KW - drug substances

KW - environmentally conscious manufacture

UR - http://pubs.rsc.org/en/Content/ArticleLanding/2016/CC/C6CC01289B#!divAbstract

U2 - 10.1039/C6CC01289B

DO - 10.1039/C6CC01289B

M3 - Article

JO - Chemical Communications

JF - Chemical Communications

SN - 1359-7345

ER -